Crola, Catherine (2015) Crosstalk between CaMKII and ERK in the regulation of cardiac hypertrophy. [Tesi di dottorato]
Preview |
Text
Crola_Chaterine.pdf Download (1MB) | Preview |
| Item Type: | Tesi di dottorato |
|---|---|
| Resource language: | English |
| Title: | Crosstalk between CaMKII and ERK in the regulation of cardiac hypertrophy |
| Creators: | Creators Email Crola, Catherine kalesch@hotmail.it |
| Date: | 31 March 2015 |
| Number of Pages: | 33 |
| Institution: | Università degli Studi di Napoli Federico II |
| Department: | Medicina Molecolare e Biotecnologie Mediche |
| Scuola di dottorato: | Medicina molecolare |
| Dottorato: | Patologia e fisiopatologia molecolare |
| Ciclo di dottorato: | 27 |
| Coordinatore del Corso di dottorato: | nome email Avvedimento, Vittorio Enrico avvedim@unina.it |
| Tutor: | nome email Illario, Maddalena UNSPECIFIED |
| Date: | 31 March 2015 |
| Number of Pages: | 33 |
| Keywords: | Cardiac Hypertrophy; CaMKII |
| Settori scientifico-disciplinari del MIUR: | Area 06 - Scienze mediche > MED/04 - Patologia generale |
| Aree tematiche (7° programma Quadro): | SALUTE e TUTELA DEL CONSUMATORE > Biotecnologie, strumenti e tecnologie generiche per la salute umana |
| Date Deposited: | 09 Apr 2015 12:09 |
| Last Modified: | 07 May 2016 01:00 |
| URI: | http://www.fedoa.unina.it/id/eprint/10400 |
| DOI: | 10.6092/UNINA/FEDOA/10400 |
Collection description
Aims: Activation of Ca2+/Calmodulin protein kinase II (CaMKII) is an important step in signaling of cardiac hypertrophy. The molecular mechanisms by which CaMKII integrates with other pathways to develop cardiac hypertrophy are incompletely understood. We hypothesize that CaMKII association with extracellular regulated kinase (ERK), promotes cardiac hypertrophy through ERK nuclear localization. Methods and results: In H9C2 cardiomyoblasts, the selective CaMKII peptide inhibitor AntCaNtide, its penetratin conjugated minimal inhibitory sequence analog tat-CN17β, and the MEK/ERK inhibitor UO126 all reduce phenylephrine (PE)-mediated ERK and CaMKII activation and their interaction. Moreover, AntCaNtide or tat-CN17β pretreatment prevented PE induced CaMKII and ERK nuclear accumulation in H9C2s and reduced the hypertrophy responses. To determine the role of CaMKII in cardiac hypertrophy in vivo, spontaneously hypertensive rats were subjected to intramyocardial injections of AntCaNtide or tat-CN17β. Left ventricular hypertrophy was evaluated weekly for 3 weeks by cardiac ultrasounds. We observed that the treatment wit CaMKII inhibitors induced similar but significant reduction of cardiac size, left ventricular mass, and thickness of cardiac wall. The treatment with CaMKII inhibitors caused a significant reduction of CaMKII and ERK phosphorylation levels and their nuclear localization in the heart. Conclusion: These results indicate that CaMKII and ERK interact to promote activation in hypertrophy; the inhibition of CaMKII-ERK interaction offers a novel therapeutic approach to limit cardiac hypertrophy.
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |
